The Mechanism of Development of the Antitumoral Immune Answer

 
 

The introduction of simulators of tumoral antigens
stimulates the production of antitumoral T-lymphocytes

Fig. 1

The antitumoral T-lymphocyte can bind  with only the
tumoral cell but does not bind with a normal cell

There is no close contact
Tcere is a close contact
Fig. 2

The search of tumor cells with a help of the antitumoral T-lumphocytes

The more the molecules of HLA-A on a tumoral cell, the better it is notable for the antitumoral T- lymphocyte
Fig. 3

The destruction of tumor cells by T-lymphocyte

After a close contact with tumor cell the T-lymphocyte starts to excrete perforins, which incorporate into the membrane of the tumor cell.
 

The perforins form a pore in the tumor cell. Through this pore water starts to enter into the tumor cell. The cell swells out, bursts off and dies, where as the T-lymphocyte searches for a new target cell for the next attack.

Fig. 4
                 [ Home page ][ Contact us ][ Site map ]

 

 

Site map

•The main page. Anticancer vaccine RESAN. A short instruction

•Indications and dosages

•The list of malignant tumors susceptible to RESAN immunotherapy

•The antigenic composition of RESAN

•The mechanism of development of antitumor immune answer by RESAN

•The interaction between the immune system and tumors

•The traditional standard methods are unable to solve the problems of metastases and relapses of malignant tumors

•The most rational use of RESAN in immunotherapy of cancers

•Immunotherapy of advanced cancers

•Vaccination for the prevention of different types of tumors

•FAQs - immunotherapy of tumors using RESAN

•FAQs -The FDA approval and other moments...

•The lab testing for RESAN vaccine

•Immunotherapy of benign prostatic hyperplasia, prostate adenoma and prostate cancer

•Vaccinotherapy of mastopathy and breast cancer

•Immunotherapy of endometriosis

•Immunotherapy of uterine myoma

•Revaccination to maintain further the anticancer immune activities

Anticancer Vaccine RESAN